Abbott Laboratories (ABT)
- Sector
- Health Care
- Industry
- Health Care Equipment
- Last price
- $102.97
- As of
Kresmion compiles this page from ABT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ABBOTT LABORATORIES (ABT): 8 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-20.
See the full ABT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ABT on one page. Preview it with sample data, then open it live with a free account.
Preview the ABT dossierActive signals for ABT
- highCONSENSUS_BUY
8 tracked funds increased ABT this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +298% to ABT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1224% to ABT (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 51% of ABT (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +130% to ABT (2026Q2)
FREE, NO ACCOUNT
Every signal on ABT, as it fires
You are seeing 5 of 87 signals recorded on ABT since 2026-05-05.
The five above landed across 2 days. The other 82 were recorded on 22 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ABT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 002824100 · 2026Q2 | $780.1M | 0.09% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 002824100 · 2026Q2 | $737.4M | 0.53% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 002824100 · 2026Q2 | $326.7M | 0.12% | , |
| Point72 Asset Management, L.P.CUSIP 002824100 · 2026Q2 | $140.8M | 0.16% | , |
| D. E. Shaw & Co., Inc.CUSIP 002824100 · 2026Q2 | $132.3M | 0.06% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 002824100 · 2026Q2 | $62.3M | 0.09% | , |
| Bridgewater Associates, LPCUSIP 002824100 · 2026Q2 | $5.4M | 0.02% | , |
| SOROS FUND MANAGEMENT LLCCUSIP 002824100 · 2026Q2 | $4.1M | 0.05% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ABT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ABT against its peers
ABT's operating margin of 18.2% ranks in the 50th percentile of 14 Health Care Equipment sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-06-30.
| Metric | ABT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 44.3B USD | 7.1B USD | 97 | 14 |
| Gross margin | n/a | 61.8% | n/a | 11 |
| Operating margin | 18.2% | 18.3% | 50 | 14 |
| Net margin | 14.7% | 13.2% | 63 | 14 |
| Return on equity | 12.5% | 13.2% | 50 | 14 |
| P / E | 27.7x | 33.5x | 46 | 13 |
| 1 year | -22.7% | -5.5% | 23 | 14 |
Peers (14): ISRG, MDT, SYK, BSX, EW, IDXX, RMD, DXCM, GEHC, STE, RVTY, ZBH, BAX, PODD. Left out: BDX (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ABT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ABT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ABT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.